1 What is this medicine
and what is it used for?
Oxcarbazepine is an antiepileptic medicine that blocks
voltage-gated sodium channels in neuronal membranes, stabilising them in an
inactive state and preventing repetitive firing that leads to seizures. It is
the 10-keto analogue of carbamazepine with a broadly similar mechanism but
improved tolerability and fewer drug interactions.
Trileptal suspension is used to treat:
• Focal (partial) seizures — with or
without secondary generalisation — as monotherapy or adjunctive therapy in
adults and children aged 2 years and older.
The liquid suspension is particularly useful for children,
patients who have difficulty swallowing tablets, and for precise dose
titration.
2 How to take this
medicine
Always use the graduated oral syringe provided to measure
each dose accurately — do not use kitchen spoons. Shake the bottle well for at
least 10 seconds before each use. The suspension may be mixed with a small
glass of water or taken directly.
Typical adult dose (monotherapy): start 300 mg twice daily;
increase by 300 mg/day at weekly intervals to 600–1200 mg/day in two divided
doses. Maximum: 2400 mg/day. Children (2–17 years): 8–10 mg/kg/day in two
divided doses (adjust per weight). Your neurologist will prescribe the exact
dose and titration schedule.
|
Shake the bottle for
10 seconds before every dose. Use the oral syringe
provided — measure carefully from the bottom of the plunger. Never stop Trileptal
suddenly — abrupt withdrawal can trigger severe seizures. Always taper
gradually under medical supervision. |
3 Possible side effects
|
Frequency |
Side Effect |
What to Do |
|
Very Common (>10%) |
Dizziness / somnolence
(drowsiness) |
Take main dose in the
evening if tolerated. Avoid driving or machinery until stabilised. |
|
Very Common (>10%) |
Headache |
Paracetamol as needed;
usually decreases with continued use. |
|
Very Common (>10%) |
Diplopia (double
vision) / blurred vision |
Usually dose-related.
Report to neurologist — dose reduction may resolve. |
|
Very Common (>10%) |
Nausea / vomiting |
Take with food;
usually improves after a few weeks. |
|
Very Common (>10%) |
Fatigue |
Allow time for the
body to adjust; usually improves. |
|
Common (1–10%) |
Hyponatraemia (low
blood sodium) |
Risk increases with
dose and with diuretics or elderly patients. Symptoms: headache, nausea,
confusion, seizures. Sodium levels monitored. |
|
Common (1–10%) |
Skin rash |
Report any skin rash
promptly — rare risk of Stevens-Johnson syndrome (SJS) or toxic epidermal
necrolysis (TEN), especially in HLA-B*1502-positive individuals. |
|
Uncommon |
Atrioventricular
conduction disturbances (bradycardia) |
Inform doctor if
pre-existing heart conduction problems. |
|
Seek help urgently |
Widespread painful
blistering skin rash, mouth sores, fever (signs of SJS/TEN) |
Stop immediately and
seek emergency medical attention. |
|
HYPONATRAEMIA WARNING: Oxcarbazepine can cause low blood sodium
(hyponatraemia) — more commonly than carbamazepine. Monitor serum sodium
before starting, at 2–4 weeks, and periodically thereafter, especially in
elderly patients or those taking diuretics or other drugs that lower sodium. Symptoms of low sodium include: headache,
nausea, confusion, difficulty concentrating, and in severe cases, seizures or
coma. SKIN ALERT: Patients of Han Chinese or Thai
descent should be tested for HLA-B*1502 before starting — this allele is
strongly associated with severe skin reactions (SJS/TEN) with sodium
channel-blocking antiepileptics. |
||
4 Who should not take
this medicine
Oxcarbazepine should not be used in: known hypersensitivity
to oxcarbazepine or carbamazepine (cross-reactivity exists in approximately
25–30% of patients with carbamazepine hypersensitivity); and atrioventricular
block (use with caution).
Use with caution in: renal impairment (CrCl < 30 mL/min —
halve the starting dose); hepatic impairment; heart failure; the elderly; and
pregnancy (category C — discuss benefit vs risk).
5 Drug interactions
• CYP3A4/5 substrates (hormonal
contraceptives, ciclosporin, calcium channel blockers, some statins):
oxcarbazepine induces CYP3A4/5 and reduces levels — use alternative
contraception (barrier method or IUD).
• Strong CYP inducers (rifampicin,
phenobarbital, phenytoin, carbamazepine): reduce oxcarbazepine active
metabolite levels.
• Other sodium channel-blocking
antiepileptics (lamotrigine, carbamazepine): additive CNS depression and sodium
channel blockade.
• Diuretics / desmopressin / NSAIDs:
additive hyponatraemia risk.
• Alcohol: additive CNS depression —
avoid.
6 Storage
Store at room temperature (below 30°C). Do not refrigerate or
freeze. Keep bottle tightly closed between doses. After opening, use within the
period stated on the label (typically 7–10 weeks for the suspension). Keep out
of reach of children.
7 Prescription
requirement
|
PRESCRIPTION ONLY
MEDICINE (POM) — Initiated by a neurologist or epilepsy specialist. Sodium levels should
be monitored regularly. Driving restriction advice should follow local
epilepsy and DVLA/transport authority guidelines. |
8 Guidance for patients
& caregivers
Trileptal suspension needs to be shaken well before every
dose — the particles settle at the bottom and an unshaken bottle will give an
inaccurate dose. Use the oral syringe carefully, checking the graduation marks
at eye level.
Hyponatraemia (low sodium) is a particular risk with
oxcarbazepine. Symptoms can be subtle — if you notice unusual confusion,
headache, or generally feeling unwell between your regular blood test
appointments, contact your doctor or epilepsy nurse.
If you are using hormonal contraception (pill, patch, ring),
oxcarbazepine reduces its effectiveness significantly. Use additional
non-hormonal contraception (barrier method) to prevent unintended pregnancy.
9 Pharmacist &
prescriber notes
Oxcarbazepine is a prodrug rapidly converted to its active
metabolite, the monohydroxy derivative (MHD / licarbazepine). Pharmacokinetics
are more predictable than carbamazepine (autoinduction not seen with
oxcarbazepine). Sodium monitoring: baseline, 2–4 weeks, then 3–6 monthly — more
frequently in at-risk patients. The active metabolite is primarily renally
excreted — halve starting dose in CrCl <30 mL/min. The 60 mg/mL suspension
with the graduated oral syringe is the ideal formulation for paediatric dosing;
confirm the volume in mL at dispensing (e.g. for a 20 mg/kg/day child weighing
20 kg = 400 mg/day = 6.67 mL/day in 2 divided doses of 3.33 mL each).
Cross-hypersensitivity with carbamazepine: approximately 25–30% — use a
different drug class if carbamazepine caused a severe rash.
10 Frequently asked
questions
Is this medicine safe in children?
Yes — Trileptal is licensed from age
2 years. The suspension is particularly suitable for children as doses can be
measured precisely by weight. It is well-tolerated in children at appropriate
doses.
My carbamazepine gave me a rash — can I take oxcarbazepine?
There is approximately a 25–30%
chance of cross-reactivity in people who had a rash from carbamazepine. Discuss
carefully with your neurologist — if carbamazepine caused a serious skin
reaction (e.g. SJS), oxcarbazepine should usually be avoided.
Does this medicine affect my contraceptive pill?
Yes — oxcarbazepine significantly
reduces the blood levels of hormonal contraceptives (pill, patch, implant),
potentially making them ineffective. Use a reliable barrier method of
contraception in addition to any hormonal contraception.
Can I drive while taking Trileptal?
Initial treatment may cause
dizziness, drowsiness, and double vision — do not drive until stabilised on a
dose that does not cause these effects. Additionally, driving regulations for
people with epilepsy vary by country — check local DVLA/licensing authority
rules.
What happens if I accidentally give a double dose to my
child?
Contact your doctor or pharmacist
immediately. Symptoms of overdose include drowsiness, dizziness, nausea, and, rarely, cardiac effects. Keep the poison control centre number accessible.